Welcome to our dedicated page for Xiao-I Corporation SEC filings (Ticker: AIXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating VIE risk factors, patent litigation updates or fresh R&D figures inside Xiao-I’s dense disclosures can feel like decoding a neural network. The company’s AI industrialization model spans software sales, MaaS subscriptions and cross-border IP, making each SEC filing uniquely complex.
Stock Titan turns those pages into clarity. Want the Xiao-I Corporation annual report 10-K simplified? Our AI pinpoints where VIE structures impact cash flows. Need a Xiao-I Corporation quarterly earnings report 10-Q filing broken into segment revenue and R&D trend lines? You’ll get instant charts plus plain-English context. When an 8-K drops, we flag the headline in seconds—consider the Xiao-I Corporation 8-K material events explained.
Real-time monitoring matters, too. Track Xiao-I Corporation insider trading Form 4 transactions alongside patent updates. Set alerts for Xiao-I Corporation Form 4 insider transactions real-time to spot executive buys or sells before market chatter spreads. Our platform also answers practical questions investors ask every quarter:
- “How is subscription (MaaS) growth disclosed?” – see the earnings footnotes.
- “Where are litigation reserves recorded?” – highlighted in 10-K legal contingencies.
- “What’s behind R&D spikes?” – AI links commentary to line-item data.
From Xiao-I Corporation proxy statement executive compensation detail to Xiao-I Corporation earnings report filing analysis, Stock Titan delivers understanding Xiao-I Corporation SEC documents with AI. Skip the jargon, keep the insight.
Xiao-I Corporation (AIXI) has entered into two Securities Purchase Agreements with institutional investors to issue unsecured 12-month convertible promissory notes with an aggregate face value of $6.128 million and gross cash proceeds of $5.610 million. The $0.518 million original-issue discount (OID) will be added to principal 30 days after the purchase date, increasing the outstanding balance subject to conversion.
The notes bear 6% annual interest (rising to 18% upon default) and are convertible into American Depositary Shares (ADSs) at the lower of (i) a fixed $3.04428 or (ii) 85% of the lowest 10-day VWAP, less a $0.05 per-ADS fee, creating material dilution potential. Each ADS represents three ordinary shares.
Key protections & risks:
- Investors may not exceed 9.99% / 4.99% beneficial ownership caps, limiting single-holder control.
- Prepayment is allowed at 101% of outstanding balance within 30 days, 110% thereafter; prepayment barred during default.
- A broad list of “Trigger Events” can increase principal by 10-15% and escalate interest to 18%, highlighting covenant-breach risk.
- No placement agent was used; conversion shares are covered by an effective F-3 shelf (File No. 333-279306).
Overall, the transaction supplies short-term liquidity but introduces near-term dilution at a potentially steep discount and embeds punitive default mechanics.
Xiao-I Corporation (Nasdaq: AIXI) has filed a Rule 424(b)(5) prospectus supplement covering up to US$6.128 million of American Depositary Shares (ADSs) that may be issued upon conversion of two privately-placed convertible promissory notes maturing on 19 June 2026. The notes were sold to two institutional investors under separate Securities Purchase Agreements dated 18 June 2025. Each ADS represents three ordinary shares, par value US$0.00005. The notes are initially debt instruments but will convert into equity at the investors’ option, creating potential dilution for existing shareholders.
The filing states that the company’s public float is approximately US$45.7 million, calculated from 36,353,875 ordinary shares held by non-affiliates and a May 13 2025 ADS closing price of US$3.77. Because the float is below US$75 million, Xiao-I is subject to Form F-3 Instruction I.B.5, which limits primary offerings to one-third of public float in any 12-month period; management confirms that the cumulative securities sold in the past year, including this note issuance, remain below that threshold, preserving additional capital-raising capacity.
Xiao-I is an “emerging growth company” and a Cayman Islands holding company whose operations are conducted in the People’s Republic of China through a variable interest entity (VIE), Shanghai Xiao-i Robot Technology Co., Ltd. U.S. GAAP consolidation is achieved via contractual agreements, yet investors purchase equity only in the Cayman parent. The filing reiterates that Chinese regulators could disallow the VIE structure, potentially rendering the ADSs valueless, and notes the VIE agreements have not been tested in court.
Extensive disclosure highlights restrictions on cash transfers, dividend payments, and foreign-exchange conversion. Dividends from the PRC operating entities can be paid to the Cayman parent only after meeting statutory reserve requirements and SAFE procedures. Currency controls, potential tightening of capital regulations, and unregistered shareholder transactions under SAFE Circular 37 all present additional hurdles. Management indicates no near-term intent to pay dividends and plans to retain earnings for growth.
Cash-management policies require multi-level approvals for inter-company transfers. While a new capital account with Bank of Ningbo has been opened, future regulatory changes or bank policy shifts could impede the movement of overseas proceeds into China. The prospectus therefore frames the offering as a financing tool for working capital and expansion, while cautioning investors about significant structural, regulatory, and dilution risks.